Autoimmune Rheumatologic Disease: Clinical Trials

1 trial for Autoimmune Rheumatologic Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1
Phase 21Recruiting 1

Follow Autoimmune Rheumatologic Disease: new trials by email Literature Review of Autoimmune Rheumatologic Disease trials Research Report on Autoimmune Rheumatologic Disease

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Controlling Hyperactive Immunity With Long-lived Lymphocytes
QEL-005 - Diffuse Cutaneous Systemic Sclerosis, Rheumatoid Arthritis (RA)
Phase 1 / Phase 2RecruitingQuell Therapeutics Limited162026-04-102026-10-19

Narrower conditions

Arthritis, Rheumatoid (1)  ·  Scleroderma, Diffuse (1)  ·  Scleroderma, Systemic (1)

Broader conditions

Arthritis (1)  ·  Autoimmune Diseases (1)  ·  Connective Tissue Diseases (1)  ·  Immune System Diseases (1)  ·  Joint Diseases (1)  ·  Musculoskeletal Diseases (1)  ·  Rheumatic Diseases (1)  ·  Skin Diseases (1)  ·  Skin and Connective Tissue Diseases (1)

Sponsors

Quell Therapeutics Limited (1)

Countries

Germany (1)  ·  Spain (1)  ·  United Kingdom (1)

NIH funding

2025 (1)